Shannon Rives
Family · Flowood, MSNPI 1447407895
Payments from drug & device makers
Across 258 payments — averaging $19.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$830
- Boehringer Ingelheim$731
- AbbVie$451
- Actelion Pharmaceuticals US, Inc.$429
- AstraZeneca$332
- Merck$324
- plus $2K from 22 others
What the payments were for
- Food & beverage$4,94698%
- Education$220%
- Gifts$762%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 49 | $830 |
| Boehringer Ingelheim | 41 | $731 |
| AbbVie | 24 | $451 |
| Actelion Pharmaceuticals US, Inc. | 16 | $429 |
| AstraZeneca | 19 | $332 |
| Merck | 15 | $324 |
| Pfizer | 18 | $301 |
| Mallinckrodt Hospital Products Inc. | 13 | $294 |
| Regeneron Healthcare Solutions, Inc. | 11 | $280 |
| Sanofi | 11 | $233 |
| Bayer | 8 | $142 |
| United Therapeutics Corporation | 5 | $77 |
| Chiesi USA, Inc. | 1 | $76 |
| Pulmonx Corporation | 4 | $72 |
| Insmed, Inc. | 4 | $69 |
| Verona Pharma, Inc. | 3 | $55 |
| La Jolla Pharmaceutical Company | 2 | $47 |
| Astellas Pharma US Inc | 2 | $44 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $40 |
| Johnson & Johnson | 2 | $39 |
| Vertex | 1 | $29 |
| Mauna Kea Technologies, Inc. | 1 | $27 |
| Inari Medical, Inc. | 1 | $25 |
| Vapotherm Inc | 1 | $24 |
| Aimmune Therapeutics, Inc. | 1 | $23 |
| Mylan Specialty L.p. | 1 | $22 |
| Genentech USA, Inc. | 1 | $15 |
| Nestle Healthcare Nutrition Inc. | 1 | $13 |
How this compares
$5,044 in reported general payments places this provider in the 90th percentile of 3,007 family providers in Mississippi.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| TrikaftaElexacaftor/Tezacaftor/Ivacaft | 132 | $3,428,742 |
| CreonLipase/Protease/Amylase | 62 | $406,184 |
| ZenpepLipase/Protease/Amylase | 15 | $77,685 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 73 | $54,626 |
| Incruse ElliptaUmeclidinium Bromide | 36 | $13,779 |
| Breo ElliptaFluticasone/Vilanterol | 33 | $12,676 |
| Spiriva HandihalerTiotropium Bromide | 11 | $11,846 |
| Tiotropium Bromide | 16 | $10,111 |
| Spiriva RespimatTiotropium Bromide | 11 | $9,603 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 13 | $9,085 |
| Combivent RespimatIpratropium/Albuterol Sulfate | 13 | $6,292 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 169 | $6,240 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 26 | $3,310 |
| Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate | 13 | $3,096 |
| Ventolin HfaAlbuterol Sulfate | 19 | $1,258 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| VertexTrikafta | $29 | $3,428,742132 claims |
| AbbVieCreon | $451 | $406,18462 claims |
| GSKTrelegy Ellipta, Incruse Ellipta, Breo Ellipta | $830 | $81,081142 claims |
| Aimmune Therapeutics, Inc.Zenpep | $23 | $77,68515 claims |
| Boehringer IngelheimSpiriva Respimat, Combivent Respimat | $731 | $15,89624 claims |
| AstraZenecaBreztri Aerosphere | $332 | $9,08513 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 3,007 family providers in Mississippi.
Other family in Flowood
- Maranda EversollFlowood$197K
- Ashley CocilovaFlowood$72K
- Tina GreggFlowood$20K
- Christina PerkinsFlowood$14K
- Jordan SmithFlowood$12K
- Shara BeckwithFlowood$12K
- Cinda PerrymanFayette$888K
- Dodie McGeeRaymond$772K
- Gina BurgeJackson$237K
- Christy DavisJackson$208K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.